Plunkett Research Online: Biosyent Inc.

BIOSYENT INC. (RX:TSX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

BioSyent Inc. is a specialty pharmaceutical company whose wholly-owned subsidiary, BioSyent Pharma Inc., sources, acquires or in-licences pharmaceutical products and markets these products in Canada......



Biosyent Inc.
Ticker: RX
Exchange: TSX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 905 206-0013
Fax: 905 206-1413
Address: 170 Attwell Drive
Suite 520
Toronto, ON M9W 5Z5 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Alfred D'SouzaCFO/Vice President, Divisional
Rene GoehrumChairman of the Board/President/Director/CEO
See More
BioSyent Inc. is a specialty pharmaceutical company whose wholly-owned subsidiary, BioSyent Pharma Inc., sources, acquires or in-licences pharmaceutical products and markets these products in Canada......See More See More

Auditor: MNP LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: